October 11, 2024
Keio University School of Medicine
A research group including Assistant Professor Sho Uemura from the Department of Surgery (General and Gastroenterological), Keio University School of Medicine; Professor Yasuaki Kabe from the Department of Basic Medical Sciences, Faculty of Medicine, Kochi University (at the time of the research, an Associate Professor at the Department of Biochemistry, Keio University School of Medicine); and Professor Yuko Kitagawa and Associate Professor Minoru Kitago from the Department of Surgery (General and Gastroenterological), Keio University School of Medicine, has discovered that the prognosis of invasive ductal adenocarcinoma of the pancreas can be predicted by detecting exosomes with mutated O-glycans in the blood before and after surgery using a new diagnostic technology. This discovery is expected to lead to the early prediction of postoperative recurrence of pancreatic cancer and the realization of personalized treatment strategies for patients. These research findings were published in the online edition of the scientific journal Cancer Science on September 16, 2024 (US time).
Please see below for the full press release.